Guilin Sanjin Pharmaceutical Co., Ltd. at its Annual General Meeting of 2022 held on 19 May 2023, approved cash dividend/10 shares (tax included): CNY 4.00000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.73 CNY | -0.34% | -0.47% | +1.66% |
04-26 | Guilin Sanjin Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 | CI |
04-25 | Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.66% | 1.2B | |
+43.17% | 6.16B | |
-14.69% | 4.46B | |
-8.17% | 3.27B | |
+6.95% | 3.2B | |
-1.76% | 2.6B | |
+50.20% | 1.98B | |
-7.85% | 1.7B | |
-0.40% | 1.66B | |
-9.91% | 1.61B |
- Stock Market
- Equities
- 002275 Stock
- News Guilin Sanjin Pharmaceutical Co., Ltd.
- Guilin Sanjin Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022